Jp Arsdale

John-Paul "JP" Van Arsdale is a long-tenured private-investing professional at Glade Brook Capital Partners, a global growth-equity firm founded in 2011 and based in Greenwich, Connecticut (with a Miami office). He earned a B.S. in International Business and Finance from Georgetown University (1997–2001), reportedly graduating Magna Cum Laude, and began his finance career on Wall Street — with early analyst/associate roles cited at firms including Morgan Stanley and Lehman Brothers. He later became a Director in the Media, Communications & Technology (TMT) investment-banking group at Barclays, working across New York and London on M&A and corporate finance for technology and media companies.

Van Arsdale joined Glade Brook in 2014 as a Managing Director focused on private investments, and has been described in various sources as a Partner and as head of the firm's private-equity execution/portfolio work. Glade Brook builds high-conviction, concentrated positions in leading late-stage private technology companies — its reported portfolio has included names such as SpaceX, Stripe, and Revolut — partnering closely with founders and management teams on long-term value creation.

From roughly 2021 to 2023, Van Arsdale served as a General Partner at BAM Elevate, the growth-stage technology investing arm associated with Balyasny Asset Management, before returning to Glade Brook. Since 2024, sources describe his role at Glade Brook in "Portfolio Optimization," and the firm's current site lists him among its Strategic Advisors, indicating an evolution from an active deal-leading partner toward an advisory/portfolio-oversight capacity. Over his career he has taken board seats at several portfolio companies, including Good Eggs, Capsule, and Leap, Inc.

• Stage & style: Institutionally, invests through Glade Brook's growth-equity strategy — concentrated, high-conviction positions in category-leading private technology companies, typically at Series A–D and later stages rather than pre-seed/seed.
• Sectors: TMT and consumer-facing technology — spanning fintech, AI, healthcare/health services (e.g., digital pharmacy), grocery/marketplace and logistics, and consumer internet.
• What makes them say yes: Glade Brook emphasizes partnering with strong founders and management teams, disciplined research, and leveraging its ecosystem relationships and capital-markets experience to support companies from private growth through liquidity — a "partners for growth" posture.
• Note on classification: The provided stub labeling him an "Angel Investor" writing "Seed Round" checks is not corroborated by public sources; his documented activity is late-stage/growth equity via Glade Brook. Any personal angel/seed investing is plausible but undocumented — treat the seed/angel framing with caution.